SC
MACK

Sepio Capital’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Sepio Capital’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-298,545
Closed -$4.41M – 290
2024
Q1 		$4.41M Sell
298,545
-8,135
-3% -$114K 0.38% 48
2023
Q4 		$4.11M Hold
306,680
– – 0.35% 47
2023
Q3 		$3.78M Buy
306,680
+12,135
+4% +$147K 0.33% 68
2023
Q2 		$3.62M Hold
294,545
– – 0.29% 91
2023
Q1 		$3.62M Hold
294,545
– – 0.33% 82
2022
Q4 		$3.38M Hold
294,545
– – 0.29% 91
2022
Q3 		$1.1M Sell
294,545
-21,768
-7% -$100K 0.11% 181
2022
Q2 		$1.88M Buy
316,313
+19,767
+7% +$112K 0.19% 142
2022
Q1 		$1.88M Buy
296,546
+217,717
+276% +$1.22M 0.16% 155
2021
Q4 		$308K Hold
78,829
– – 0.02% 326
2021
Q3 		$381K Sell
78,829
-142,610
-64% -$744K 0.03% 299
2021
Q2 		$1.42M Buy
221,439
+2,532
+1% +$16.7K 0.12% 210
2021
Q1 		$1.38M Buy
218,907
+25,431
+13% +$182K 0.13% 194
2020
Q4 		$1.33M Sell
193,476
-1,309
-0.7% -$6.46K 0.12% 199
2020
Q3 		$779K Sell
194,785
-15,749
-7% -$57.9K 0.08% 198
2020
Q2 		$701K Sell
210,534
-143,110
-40% -$488K 0.08% 194
2020
Q1 		$760K Sell
353,644
-42,540
-11% -$124K 0.1% 138
2019
Q4 		$1.25M Buy
396,184
+166,708
+73% +$668K 0.12% 140
2019
Q3 		$1.03M Buy
+229,476
New +$1.15M 0.11% 151
2019
Q1 		– Sell
-523,240
Closed -$1.59M – 343
2018
Q4 		$1.59M Buy
+523,240
New +$1.81M 0.12% 118

Other funds holding MACK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
RA
Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Sepio Capital's MACK Position: Q2 2024 in Review

Sepio Capital sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2024, closing a stake of 298,545 shares — an estimated $4.41M sold.

Sepio Capital first reported a position in MACK in Q4 2018 and held it in 20 quarters. The position peaked at $4.41M in Q1 2024. 12 funds tracked by Wall St. Rank hold MACK as of Q2 2024.

  • Sepio Capital reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
  • Sepio Capital sold 298,545 Merrimack Pharmaceuticals, Inc. shares in Q2 2024, an estimated $4.41M.
  • Sepio Capital first reported a position in Merrimack Pharmaceuticals, Inc. in Q4 2018 and held it in 20 quarters.
  • Sepio Capital's Merrimack Pharmaceuticals, Inc. position peaked at $4.41M in Q1 2024.
  • 12 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2024.

Based on Sepio Capital's 13F filing for Q2 2024, filed 15 Aug 2024.